[b] Aims to protect the rights and safety of the research subjects.
[c] Does not aim to prevent fraud and misconduct.
[d] Is outlined in ICF document E3.
Answer b
11 Which of the following would you most often associate
Phase IV Trials
with?
[a] Human Pharmacology
[b] Therapeutic Use
[c] Therapeutic Confirmatory
[d] Therapeutic Exploratory
Answer b
12 In which clinical phase would you generally expect the trials
to be
conducted in a group of patients who are selected by relatively
narrow
criteria, leading to a relatively homogeneous population which
are closely
monitored during the trial and the trial is examining
therapeutic efficacy?
[a] Phase I
[b] Phase II
[c] Phase IIIa
[d] Phase IIIb
Answer b
13 Phase I clinical trial look at the pharmacokinetics of a test
product. Whichof the following statements is not true about
pharmacokinetics?
[a] Pharmacokinetics looks at whether the product demonstrates
efficacy
[b] Pharmacokinetics looks at how the product is excreted from the
body
[c] Pharmacokinetics looks at what the body does to the product
[d] Pharmacokinetics looks at how the product is metabolised by the
body
Answer a
Answer c
STU